Subsequent work by other investigators has only served to establish more firmly that α-synuclein demonstrates neurotoxicity only at the very highest levels of expression achievable and does not drive the development of cardinal symptoms of PD (Terzioglu and Galter, 2008). This evidence concerns the gene SNCA and Parkinson disease.